助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[399]条 当前为第1条到20条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
transitional cell carcinoma
Nephroureterectomy with removal of a bladder cuff was performed successfully on a 47-year-old man for transitional cell carcinoma of the right renal pelvis using hand-assisted laparoscopy.
      
Alteration of G1-cyclins (D1 and E) in transitional cell carcinoma of human urinary bladder with infection of HPV-18
      
Objective: This study was designed to investigate differential pattern of G1-cyclins (D1 and E) in transitional cell carcinoma (TCC) of human urinary bladder with or without human papillomavirus-18 (HPV-18) infection.
      
Recurrence risk factors in patients with transitional cell carcinoma of bladder
      
Methods: An analysis on recurrence-related factors was made by Cox's proportional hazards model analysis and logistic multiple linear regression model analysis in 212 patients with transitional cell carcinoma treated surgically from 1995~2001.
      
Prostatic adenocarcinoma coexist with transitional cell carcinoma of the bladder and prostate - A case report and review of the
      
Prostatic adenocarcinoma(PAC) with transitional cell carcinoma(TCC) of the bladder and prostate is a rare clinicopathological entity, presentation is usually late.
      
The expression and significance of KAI1 and Ki67 in bladder transitional cell carcinoma
      
MDR1/P-glycoprotein overexpression in bladder transitional cell carcinoma and its correlation with expression of survivin and Fa
      
OBJECTIVE To explore the expression of the MDR1/P-glycoprotein, Fas and survivin and to examine their correlation with the biologic behavior of bladder transitional cell carcinoma (BTCC).
      
The combination of methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) has been the standard therapy for transitional cell carcinoma for over a decade.
      
Transitional cell carcinoma of the bladder: New approaches to the treatment of advanced disease
      
Combined chemotherapy and external beam radiotherapy for transitional cell carcinoma of the bladder
      
A growing body of evidence supports the treatment of invasive transitional cell carcinoma of the bladder with transurethral resection, chemotherapy, and external beam radiotherapy.
      
Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials
      
The role of regional lymph node dissection (LND) in surgical management of high-grade, invasive transitional cell carcinoma of the bladder has evolved over the past several decades.
      
There are many concerns, one of which is the potential risk of metachronous and synchronous urethral transitional cell carcinoma involvement.
      
Which patients with transitional cell carcinoma of the bladder or prostatic urethra are candidates for an orthotopic neobladder
      
Presently, BCG is commonly used and is the most effective immunotherapeutic agent against superficial transitional cell carcinoma.
      
This review highlights and summarizes the recent advances concerning immunotherapy, with special emphasis on BCG therapy for transitional cell carcinoma.
      
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社